Ascendiant Capital Markets Forecasts Strong Price Appreciation for Sintx Technologies (NASDAQ:SINT) Stock

Sintx Technologies (NASDAQ:SINT) had its price target raised by investment analysts at Ascendiant Capital Markets from $12.00 to $12.50 in a research report issued on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Ascendiant Capital Markets’ price objective would suggest a potential upside of 460.54% from the company’s previous close.

A number of other research firms also recently weighed in on SINT. Maxim Group reaffirmed a “buy” rating and set a $6.00 price target on shares of Sintx Technologies in a research note on Thursday, June 4th. Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $9.50.

Sintx Technologies Trading Up 9.9%

Shares of SINT stock opened at $2.23 on Thursday. Sintx Technologies has a 1-year low of $1.40 and a 1-year high of $4.64. The firm’s 50-day simple moving average is $1.67 and its 200-day simple moving average is $2.04.

Sintx Technologies (NASDAQ:SINT) last released its earnings results on Tuesday, August 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.02). Sintx Technologies had a negative return on equity of 354.44% and a negative net margin of 848.20%.The company had revenue of $0.45 million during the quarter, compared to analyst estimates of $0.46 million. On average, equities research analysts forecast that Sintx Technologies will post -1.67 EPS for the current year.

Sintx Technologies Company Profile

SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.

The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.